15
Participants
Start Date
July 31, 2007
Primary Completion Date
October 31, 2009
Study Completion Date
January 31, 2012
ZK219477
Given intravenously over approximately 30 minutes once every 3 weeks
Dana-Farber Cancer Institute, Boston
Collaborators (2)
Brigham and Women's Hospital
OTHER
Bayer
INDUSTRY
Breast Cancer Research Foundation
OTHER
Nancy Lin, MD
OTHER